Showing results (111-120 of 177) with videos related to
Sort By:
Pageof 18
International Journal of Cancer|April 15, 1985
Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodiesW J Rettig, C Cordon-Cardo, J P Koulos, et al.Urology|November 11, 1975
Study of local and systemic effects of intravesical BCGP F Schellhammer, M H Kaplan, C M Pinsky, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patientH Yamaguchi, K Furukawa, S R Fortunato, et al.Cancer Research|January 1, 1994
GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccinesF Helling, A Shang, M Calves, et al.The Journal of Urology|April 1, 1990
The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-GuerinP R Bretton, H W Herr, M Kimmel, et al.The Journal of Investigative Dermatology|November 1, 1987
Changes in cell surface glycoprotein expression during differentiation of human keratinocytesC E Klein, C Cordon-Cardo, R Soehnchen, et al.Cancer|April 15, 1986
Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factorsS E Krown, F X Real, S Vadhan-Raj, et al.The Journal of Clinical Investigation|October 1, 1988
Tumor necrosis factor and the acute metabolic response to tissue injury in manH F Starnes, R S Warren, M Jeevanandam, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Cell-surface antigens of melanoma recognized by human monoclonal antibodiesH Yamaguchi, K Furukawa, S R Fortunato, et al.Cancer|December 15, 1986
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometryR A Badalament, H Gay, W F Whitmore, et al.Pageof 18